54 results
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
16 Oct 15
Regulation FD Disclosure
12:00am
Activator AG-519 Entering Clinical Development -
- Company to Webcast Today’s R&D Day -
Cambridge, Mass. – October 16, 2015 –Agios Pharmaceuticals … with insights into emerging research at its R&D Day today.
“With our lead IDH programs progressing through Phase 1 expansion cohorts and the initiation
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
29 Jul 21
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
7:17am
business.
Research and Development (R&D) Expenses: R&D expenses for continuing operations were $62.0 million for the second quarter of 2021 compared … to $54.1 million for the second quarter of 2020. The year-over-year increase in R&D was driven primarily by start-up costs associated with the Phase 3
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am
for the second quarter of 2019.
Research and Development (R&D) Expenses: R&D expenses were $90.9 million for the second quarter of 2020 compared … to $107.4 million for the second quarter of 2019. The decrease in R&D expense was primarily attributable to milestone payments related to AG-636
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
29 Apr 21
Agios Reports Business Highlights and First Quarter 2021 Financial Results
7:28am
Research and Development (R&D) Expenses: R&D expenses for continuing operations were $57.7 million for the first quarter of 2021 compared to $55.4 million … for the first quarter of 2020. The year-over-year increase in R&D was driven primarily by start-up costs associated with the Phase 3 studies
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
14 Feb 19
Agios Reports Fourth Quarter and Full Year 2018 Financial Results
7:16am
. Cost of sales were $0.7 million for the fourth quarter of 2018, and $1.4 million for the year ended December 31, 2018.
Research and Development (R&D) Expenses … : R&D expenses were $93.8 million for the fourth quarter of 2018 compared to $77.2 million for the fourth quarter of 2017, and $341.3 million
8-K
EX-99.1
bx3ble91eyoo
13 Feb 20
Agios Reports Fourth Quarter and Full Year 2019 Financial Results
7:40am
8-K
EX-99.1
3s5gju9k
3 Nov 21
Agios Reports Business Highlights and Third Quarter 2021 Financial Results
7:27am
8-K
EX-99.1
flmp5tc0xbov6
5 May 22
Agios Reports Business Highlights and First Quarter 2022 Financial Results
7:21am
8-K
EX-99.1
keebp
4 Aug 22
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
7:14am
8-K
EX-99.1
h85izrxfw5mpksbc9h2
24 Feb 22
Agios Reports Fourth Quarter and Full Year 2021 Financial Results
7:40am
8-K
EX-99.1
04bffak nn
30 Apr 20
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations andCOVID-19 Response
7:19am
8-K
EX-99.1
8fax3t6jc286
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
7r0sc1
4 May 18
Results of Operations and Financial Condition
7:07am
8-K
EX-99.1
1m4dq53shvgh1o8
2 Aug 18
Agios Reports Second Quarter 2018 Financial Results
7:28am
8-K
EX-99.1
89zoa
2 May 19
Agios Reports Business Highlights and First Quarter 2019 Financial Results
7:24am
8-K
EX-99.1
amr2ihatx5 tt5
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
EX-99.1
mqtq2 tblam9f2
1 Nov 18
Agios Reports Third Quarter 2018 Financial Results
7:45am
8-K
EX-99.1
smy5n5
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
8-K
EX-99.1
1u76i81f76 72j2fm
25 Feb 21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
8-K
EX-99.1
fga41d
2 Nov 23
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
7:02am